Jeremy Smith, MD
Orthopaedic Surgery of the Spine · Orange, CANPI 1629257688
Payments from drug & device makers
What this record shows
This record is dominated by royalties or licence payments: $593,768 of the $856,320 with a category attached, or 69.3%. Globus Medical accounts for 65.9% of it on its own, with 30 other manufacturers making up the rest. Among orthopaedic surgery of the spine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 729 payments — averaging $1174.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$564K
- Spineart USA Inc$144K
- Spineart SA$91K
- Surgalign Spine Technologies, Inc.$24K
- Xtant Medical Inc$15K
- Innovasis Inc$14K
- plus $4K from 25 others
Across 46 payments — averaging $1420.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Globus Medical$65K
What the payments were for
- Royalty or licence$593,76869%
- Consulting fees$102,75012%
- Travel & lodging$122,02814%
- Food & beverage$37,7554%
- Education$100%
- Gifts$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical(2 entities) | 421 | $564,404 |
| Spineart USA Inc | 165 | $144,438 |
| Spineart SA | 11 | $90,884 |
| Surgalign Spine Technologies, Inc. | 32 | $23,940 |
| Xtant Medical Inc | 7 | $14,714 |
| Innovasis Inc | 9 | $13,549 |
| Baxter Healthcare | 17 | $954 |
| Orthofix Medical, Inc. | 3 | $707 |
| Medtronic(2 entities) | 9 | $582 |
| Johnson & Johnson(2 entities) | 15 | $569 |
| Alphatec Spine, Inc | 7 | $322 |
| Osteocentric Technologies, Inc. | 4 | $264 |
| Kyocera Medical Technologies, Inc. | 1 | $143 |
| Providence Medical Technology, Inc. | 2 | $143 |
| Stryker | 2 | $82 |
| Radius Health, Inc. | 3 | $77 |
| Carlsmed, Inc. | 1 | $75 |
| Zimmer Biomet | 1 | $54 |
| Amgen | 2 | $54 |
| Alvogen Inc | 3 | $52 |
| Integrity Implants Inc. | 1 | $49 |
| Spineology Inc. | 2 | $37 |
| Seaspine Orthopedics Corporation | 2 | $33 |
| Integra Lifesciences Corporation | 1 | $29 |
| AbbVie | 1 | $29 |
| Boston Scientific | 1 | $27 |
| Ossdsign USA Incorporated | 2 | $27 |
| Intrinsic Therapeutics | 1 | $25 |
| Solventum Corporation | 1 | $24 |
| Centinel Spine, LLC | 1 | $21 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COHERE$432,420
- Scarlet AC$74,191
- Pulse$63,594
- Perla TL$46,171
- PERLA C$31,495
- CoRoent$27,049
- BAGUERA C$25,201
- XLIF$24,401
- CORTERA$17,674
- Scarlet AL-T$17,073
- ALIF$13,072
- SCARLET AL-T - SECURED LUMBAR ANTERIOR CAGE$6,825
- COFLEX INTERLAMINAR TECHNOLOGY, 10MM$5,492
- SCARLET AL-T - HYPERLORDOTIC SECURED LUMBAR ANTERIOR CAGE$4,607
- MaXcess$3,750
- Spine$2,031
- RELINE$750
- Excelsius Robotics System$742
- SCARLET AC-T$672
- FLOSEAL$388
How this compares
$856,320 in reported general payments places this provider in the 90th percentile of 288 orthopaedic surgery of the spine providers in California.
See all orthopaedic surgery of the spine providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Teriparatide | 12 | $29,411 |
| Gabapentin | 300 | $2,990 |
| Lidocaine | 21 | $2,530 |
| Pregabalin | 90 | $1,759 |
| Oxycodone Hcl | 141 | $1,644 |
| Celecoxib | 68 | $1,505 |
| Baclofen | 124 | $1,451 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 94 | $1,228 |
| Methocarbamol | 86 | $1,057 |
| Prednisone | 310 | $732 |
| Tramadol Hcl | 160 | $592 |
| Meloxicam | 88 | $458 |
| Duloxetine Hcl | 22 | $430 |
| Famotidine | 243 | $346 |
| Diclofenac Sodium | 20 | $298 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Alvogen IncTeriparatide | $52 | $29,41112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 288 orthopaedic surgery of the spine providers in California.
Other orthopaedic surgery of the spine in Orange
- Stacey BedermanOrange$3.7M
- Jeffrey DeckeyOrange$1.3M
- Nitin BhatiaOrange$1.2M
- Don ParkOrange$849K
- Jon WhiteOrange$806K
- Hyun BaeSanta Monica$56.8M
- Choll KimSan Diego$4M
- Gregory Mundisla Jolla$3.3M
- Paul SlosarDaly City$3.1M
- Babak Barcohanavan Nuys$2.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.